• Responsible for identifying and analyzing commercial potential of product opportunities across Indian ophthalmology market, specifically for Medicom Dry Eye range of products• Performing thorough marketing assessment to provide competitive intelligence support and assisting in business case preparation.• Trouble shooting various channel partners to ensure smooth supply and availability of Medicom products across distributors and digital vendors to improve market access.• Developing business relations with key stakeholders and managing portfolio for Medicom

• Responsible for stock keeping of various parts used for production line• Receiving inputs and stacking the same as per the line protocol• Ensure timely dispatch of line jobs as per the schedule after validating the job sheets• Placing orders to replenish the depleting stocks of various components required in production line

• Responsible for the Cardiology formulation portfolio comprising of flagship brands-Lastavin Family (Valsartan & its combination with Amlodipine & Hydrochlorothiazide) and Rosuchol (Rosuvastatin) for West Asia Markets Iraq comprising of 3.1 Mn USD business annually.• Also was responsible for carving out the successful Launch Plan for CINOD (Cilnidipine) molecule being launched for 1st time in Iraq.• Managed brands by conducting innovative, saleable and sustainable marketing campaigns to drive robust growth and increase prescription share.• Built relationships with Key Opinion Leaders and continually assessed selection criteria and return on investment.• Analysed business development avenues, monitored market trends through third-party data and investigated new growth opportunities.• Digital Marketing initiatives undertaken to engage Drs during the challenging times of COVID-19 outbreak and conducted therapy specific webinars with Drs in association with Provincial regulatory organizations.• Single handedly executed for the inception of unique 1st time activity of conducting ECG Interpretation workshops with Indo-Iraqi collaboration in Iraq

• Handled the entire Ophthalmology formulation portfolio single handedly for Emerging Markets comprising of 22 molecules summing up to 2.13 Mn USD annually.• Also was responsible for a part of Gastro portfolio comprising of 6 molecules worth of 4.45 Mn USD annually.• Managed the business of OMAN completely as a ‘Country Co-ordinator’.• Played a pivotal role in launching the Ophthalmology Therapy as well as various brands across markets like Nepal, Myanmar, Sri Lanka, Kenya, Tanzania and Mexico.• Was responsible for all aspects of Branding like promotion, brand building, marketing strategy planning and execution.• Training of Field force & creating Launch plans, Brand Plans.• Void Analysis in the current therapy/country of operation to forecast the possibility of New Launches, ensuring Brand Profitability and ROI in co-ordination with the Business Development team.• Tracking the dynamics of the market through market research, conducting cycle meetings and execution of overall brand strategies for KOL engagement.• Coordinating with internal teams and agencies for execution of plan

• Responsible for managing South Mumbai Territory to generate Primary and Secondary Sales.• Influencing prescription habits of customers by sharing scientific data/ updating through in-clinic communication.• Successfully launched new brands Optive Fusion, Novoret NEO, Brinzagan and handling other key brands like Lumigan, Ganfort, Optive & Zymaxid.• Conducted CMEs, Camps on regular basis to enhance awareness and knowledge of the customers to drive sales figures.• Tracked market/ competitor trends to keep abreast the changing client’s requirement/expectations.• Demonstrated team work by sharing customer targeting information, product adoption status and business plan objectives.• Chief Editor of the monthly magazine of West Zone named ‘Inspira’ which is a reflection of the performance of the sales team of West Zone for the month and motivate the team.• Played the role of a ‘Mentor’ in the ‘Peer to Peer’ mentoring program to guide colleagues in implementation of Rx Star (a selling skills enhancing program)• Also assisted few KOLs from Mumbai in developing Marketing strategies and developing a PR plan for their institutes.• Topper of the 51st Ignite training program held at Bangalore with a score of 98.99%• Won the ‘Most Bold Ignitor’ award at the 51stIgnite training program held at Bangalore.• Gold Certificate winner in I Quest (Knowledge) module held at 51st Ignite training program held at Bangalore.• Gold Certificate winner in Rx Star (Selling Skills) module held at 51st Ignite training program held at Bangalore

• Responsible for handling brands- Mactor range (Atorvastatin and its combinations with Fenofibrate, Aspirin and Ezetimibe), Voglimac range (Voglibose and its combinations with Metformin and Glimepiride), Macpril range (Ramipril and its combination with Hydrochlorothiazide), Omnitan range (Losartan and its combination with Hydrochlorothiazide) and Mefomin (Metformin).• Handled a brand portfolio of Rs.84 Cr annually.(11 Mn USD annually)• Designing and execution of promotional strategies and campaigns to enhance the brand visibility and sales.• Update consumer trends and competitor activities through fieldwork..• Responsible for strategy briefing meetings for the field force.• Successfully developed the ‘Diab@ease’ campaign for Anti-diabetic range, ‘Legends never Retire’ theme for Omnitan and ‘Stands Tall even Today’ theme for Mactor Range which attracted a thumping response from field as well as Drs.• Also assisted the GPM for the launch of Macprot DM an OTC product for diabetes patients.• Also assisted the GPM for preparing various strategies and inputs for ‘Thyrox’

1. To evaluate the usage patterns of different strengths of Diclofenac injections in nursing homes.2. To identify the reasons for the shift in preference of doctors and to suggest strategies to counter the same and revive the sales of Voveran inj.